Login / Signup

Outcomes of venetoclax-based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia.

Antoine N SalibaMark R LitzowNaseema GangatAref Al-KaliJames M ForanWilliam J HoganJeanne M PalmerAbhishek A MangaonkarAyalew TefferiMirinal S Patnaik
Published in: American journal of hematology (2021)
Keyphrases
  • acute myeloid leukemia
  • bone marrow
  • type diabetes
  • drug induced
  • replacement therapy